|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 11/07/14 Cipher Pharmaceuticals Inc 40FR12B 84:13M Merrill Corp-MD/FA |
Document/Exhibit Description Pages Size
1: 40FR12B Registration of Securities of a Canadian Issuer -- HTML 97K
SEA'34 §12(b)
2: EX-99.01 Miscellaneous Exhibit HTML 31K
3: EX-99.02 Miscellaneous Exhibit HTML 376K
4: EX-99.03 Miscellaneous Exhibit HTML 154K
5: EX-99.04 Miscellaneous Exhibit HTML 44K
6: EX-99.05 Miscellaneous Exhibit HTML 61K
7: EX-99.06 Miscellaneous Exhibit HTML 317K
8: EX-99.07 Miscellaneous Exhibit HTML 32K
9: EX-99.08 Miscellaneous Exhibit HTML 32K
10: EX-99.09 Miscellaneous Exhibit HTML 23K
11: EX-99.10 Miscellaneous Exhibit HTML 557K
12: EX-99.11 Miscellaneous Exhibit HTML 28K
13: EX-99.12 Miscellaneous Exhibit HTML 444K
14: EX-99.13 Miscellaneous Exhibit HTML 27K
15: EX-99.14 Miscellaneous Exhibit HTML 29K
16: EX-99.15 Miscellaneous Exhibit HTML 45K
17: EX-99.16 Miscellaneous Exhibit HTML 27K
18: EX-99.17 Miscellaneous Exhibit HTML 264K
19: EX-99.18 Miscellaneous Exhibit HTML 131K
20: EX-99.19 Miscellaneous Exhibit HTML 28K
21: EX-99.20 Miscellaneous Exhibit HTML 28K
22: EX-99.21 Miscellaneous Exhibit HTML 44K
23: EX-99.22 Miscellaneous Exhibit HTML 41K
24: EX-99.23 Miscellaneous Exhibit HTML 25K
25: EX-99.24 Miscellaneous Exhibit HTML 344K
26: EX-99.25 Miscellaneous Exhibit HTML 169K
27: EX-99.26 Miscellaneous Exhibit HTML 29K
28: EX-99.27 Miscellaneous Exhibit HTML 29K
29: EX-99.28 Miscellaneous Exhibit HTML 40K
30: EX-99.29 Miscellaneous Exhibit HTML 27K
31: EX-99.30 Miscellaneous Exhibit HTML 35K
32: EX-99.31 Miscellaneous Exhibit HTML 351K
33: EX-99.32 Miscellaneous Exhibit HTML 174K
34: EX-99.33 Miscellaneous Exhibit HTML 28K
35: EX-99.34 Miscellaneous Exhibit HTML 28K
36: EX-99.35 Miscellaneous Exhibit HTML 41K
37: EX-99.36 Miscellaneous Exhibit HTML 23K
38: EX-99.37 Miscellaneous Exhibit HTML 23K
39: EX-99.38 Miscellaneous Exhibit HTML 24K
40: EX-99.39 Miscellaneous Exhibit HTML 28K
41: EX-99.40 Miscellaneous Exhibit HTML 406K
42: EX-99.41 Miscellaneous Exhibit HTML 173K
43: EX-99.42 Miscellaneous Exhibit HTML 45K
44: EX-99.43 Miscellaneous Exhibit HTML 40K
45: EX-99.44 Miscellaneous Exhibit HTML 42K
46: EX-99.45 Miscellaneous Exhibit HTML 29K
47: EX-99.46 Miscellaneous Exhibit HTML 28K
48: EX-99.47 Miscellaneous Exhibit HTML 310K
49: EX-99.48 Miscellaneous Exhibit HTML 32K
50: EX-99.49 Miscellaneous Exhibit HTML 32K
51: EX-99.50 Miscellaneous Exhibit HTML 559K
52: EX-99.51 Miscellaneous Exhibit HTML 27K
53: EX-99.52 Miscellaneous Exhibit HTML 424K
54: EX-99.53 Miscellaneous Exhibit HTML 26K
55: EX-99.54 Miscellaneous Exhibit HTML 264K
56: EX-99.55 Miscellaneous Exhibit HTML 156K
57: EX-99.56 Miscellaneous Exhibit HTML 29K
58: EX-99.57 Miscellaneous Exhibit HTML 29K
59: EX-99.58 Miscellaneous Exhibit HTML 44K
60: EX-99.59 Miscellaneous Exhibit HTML 28K
61: EX-99.60 Miscellaneous Exhibit HTML 35K
62: EX-99.61 Miscellaneous Exhibit HTML 32K
63: EX-99.62 Miscellaneous Exhibit HTML 33K
64: EX-99.63 Miscellaneous Exhibit HTML 29K
65: EX-99.64 Miscellaneous Exhibit HTML 33K
66: EX-99.65 Miscellaneous Exhibit HTML 340K
67: EX-99.66 Miscellaneous Exhibit HTML 195K
68: EX-99.67 Miscellaneous Exhibit HTML 29K
69: EX-99.68 Miscellaneous Exhibit HTML 29K
70: EX-99.69 Miscellaneous Exhibit HTML 46K
71: EX-99.70 Miscellaneous Exhibit HTML 354K
72: EX-99.71 Miscellaneous Exhibit HTML 202K
73: EX-99.72 Miscellaneous Exhibit HTML 29K
74: EX-99.73 Miscellaneous Exhibit HTML 29K
75: EX-99.74 Miscellaneous Exhibit HTML 44K
76: EX-99.75 Miscellaneous Exhibit HTML 23K
77: EX-99.76 Miscellaneous Exhibit HTML 369K
78: EX-99.77 Miscellaneous Exhibit HTML 32K
79: EX-99.78 Miscellaneous Exhibit HTML 32K
80: EX-99.79 Miscellaneous Exhibit HTML 23K
81: EX-99.80 Miscellaneous Exhibit HTML 425K
82: EX-99.81 Miscellaneous Exhibit HTML 32K
83: EX-99.82 Miscellaneous Exhibit HTML 32K
84: EX-99.83 Miscellaneous Exhibit HTML 22K
Exhibit 99.83
Consent of Independent Auditor
We hereby consent to the incorporation by reference in this registration statement on Form 40-F of Cipher Pharmaceuticals Inc. of our reports dated February 25, 2014, relating to the financial statements, which comprise the balance sheets as at December 31, 2013 and December 31, 2012, and the statements of operations and comprehensive income, changes in equity and cash flows for the years ended December 31, 2013 and December 31, 2012, and February 28, 2013, relating to the financial statements, which comprise the balance sheets as at December 31, 2012 and December 31, 2011, and the statements of operations and comprehensive income (loss), changes in equity and cash flows for the years ended December 31, 2012 and December 31, 2011.
/s/ PricewaterhouseCoopers LLP
Chartered Professional Accountants, Licensed Public Accountants
Oakville, Ontario, Canada
PwC Centre, 354 Davis Road, Suite 600, Oakville, Ontario, Canada L6J 0C5
T: +1 905 815 6300, F: +1 905 815 6499, www.pwc.com/ca
“PwC” refers to PricewaterhouseCoopers LLP, an Ontario limited liability partnership.
| This ‘40FR12B’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/7/14 | F-X | ||
| 2/25/14 | ||||
| 12/31/13 | ||||
| 2/28/13 | ||||
| 12/31/12 | ||||
| 12/31/11 | ||||
| List all Filings | ||||